In this study, we retrospectively analyzed the outcomes of adults with bicuspid aortic valve (BAV)
Bicuspid aortic valve (BAV) is a congenital anomaly with an incidence of 1% to 2.5% and a higher prevalence in men.1,2 In people with BAV, 85% of subsequent valvular disease consists of aortic stenosis that presents after the 5th decade of life.3 Isolated aortic valve regurgitation is less frequent and usually manifests itself earlier in life. 4 Most patients who have BAVs associated with pure regurgitation undergo repair; however, stenotic BAVs are typically replaced with artificial valves.
5Although regurgitant BAVs are usually repaired, repaired BAVs have significant valve gradients, and early reoperation for valve replacement is necessary. 6 In addition, because most stenotic BAVs are replaced, the patients cannot avoid the sequelae associated with mechanical valves or the problems associated with bioprosthetic valves.
7As a result, neither valve replacement nor valve repair is a completely satisfactory therapeutic method for BAV disease.We treated BAV disease by performing aortic valve reconstructive surgery (AVRS) that consisted of aortic valve leaflet reconstruction with the use of pericardial patches plus fixation of the sinotubular junction (STJ), and we evaluated the early and midterm outcomes.
Patients and MethodsWe retrospectively analyzed the cases of 135 patients (99 men and 36 women; mean age, 49.2 ± 13.1 yr) who underwent AVRS for the treatment of BAV disease at